Vinay Rajani flags L&T Finance, Gland Pharma, Welspun Enterprises
Indian equities traded in a tight band around key moving averages on Monday as Nifty 50 slipped about 115 points amid geopolitical worries, with HDFC Securities’ Vinay Rajani recommending L&T Finance, Gland Pharma and Welspun Enterprises for near-term trades.
Market overview and Nifty outlook
| Index / Level | Value / Range | Move & % Change | Comments |
|---|---|---|---|
| Nifty 50 | 23,800 to 24,200 range | Approx. -115 pts from previous close | Consolidation between 20, 50 and 100 DEMA bands. |
| BSE Sensex | Not specified | Fell over 400 pts | Weak on renewed US-Iran tensions. |
Note: figures are approximate; final exchange data not available at time of publication.
- Nifty traded between last week’s high 24,261 and low 23,784 for six to seven sessions.
- Index is above 20-day and 50-day EMAs near 23,830 to 23,850.
- Nifty is capped below the 100-day EMA around 24,138 to 24,150.
- Key support zone identified at 23,800 to 23,780 on closing basis.
- A close above 24,200 could open upside toward 24,450 (near 200 DEMA).
- A decisive close below 23,800 may trigger a pullback to 23,500 to 23,300.
- Midcaps and smallcaps are losing earlier momentum, breadth has softened.
- Traders are advised to keep long positions with a closing stop at 23,800.
- Pullbacks to 20 and 50 DEMA zones seen as selective entry opportunities.
- “The market seems to be in a mood of consolidation” Vinay Rajani, Senior Technical and Derivative Analyst, HDFC Securities.
Sectoral view and preferred themes
| Sector / Theme | Direction (approx.) | Key Drivers |
|---|---|---|
| Banks & NBFCs | Relatively stronger | Holding above key averages, seen outperforming in near term. |
| Healthcare & Pharma | Outperforming | Trading near all-time highs, strong relative strength. |
| Broader market | Losing momentum | Midcaps and smallcaps showing weaker short-term charts. |
- Financials, especially banks and NBFCs, highlighted as accumulation candidates on dips.
- Healthcare and pharma indices are near all-time highs and outperforming.
- Broader market underperformance adds to cautious stance on aggressive risk.
- Rajani suggests using strength in banks, NBFCs and healthcare to add selectively.
- Primary market trend remains upward despite short-term consolidation.
Technical outlook and key risk levels
| Statistic | Value / Change | Context |
|---|---|---|
| Nifty 20 DEMA | Around 23,830 | Acts as first support in current consolidation band. |
| Nifty 50 DEMA | Around 23,850 | Coincides with support cluster near 23,800. |
| Nifty 100 DEMA | Around 24,138 to 24,150 | Immediate resistance, yet to be decisively reclaimed. |
- Nifty formed a long-leg doji last week, signalling indecision.
- Index is consolidating above 20 and 50 DEMA, below 100 DEMA.
- A confirmed breakout needs higher volume and better breadth.
- Traders are advised to add only after reclaiming the 100 DEMA with confirmation.
- Recent outperformance is giving way to what Rajani terms healthy consolidation.
Stock ideas: L&T Finance, Gland Pharma, Welspun Enterprises
L&T Finance
- L&T Finance price around ₹300 to ₹302 used as entry reference.
- Trading recommendation: go long with stop loss at ₹295 to ₹295.8.
- Near-term target indicated between ₹312 and ₹332.
- Stock has broken a downward-sloping trendline on the daily chart.
- Price breakout is supported by rising volumes.
- Sits above all key moving averages on the daily timeframe.
- Daily RSI is sustaining above 50, signalling positive momentum.
- Daily MACD has moved above equilibrium and signal line.
Gland Pharma
- Gland Pharma quoted around ₹2,360 as a reference buying zone.
- Suggested stop loss at ₹2,310 for trading positions.
- Upside target placed at ₹2,470 in the near term.
- Stock is near a breakout from a consolidation pattern.
- Primary trend for Gland Pharma remains positive.
- Pharma index and healthcare basket are trading near all-time highs.
Welspun Enterprises
- Welspun Enterprises entry reference around ₹573.
- Recommended stop loss at ₹514.
- Upside target projected at ₹640.
- Weekly chart shows a descending triangle breakout.
- Price rise is accompanied by higher volumes.
- Stock trades above all key moving averages.
- Weekly RSI is sustaining above 50.
- Weekly MACD has crossed above equilibrium and signal lines.
Macro and global cues
| Market / Data | Movement | Notes |
|---|---|---|
| US-Iran geopolitical tensions | Negative for risk | Fresh military exchanges weighing on sentiment. |
| Domestic macro data | Upcoming | IIP, fiscal deficit, PMI and FX reserves in focus. |
- Renewed US-Iran tensions pressured Indian equities after a muted open.
- Investors await industrial production, fiscal deficit and PMI readings.
- Latest foreign exchange reserves data will be watched for macro strength.
- These indicators are expected to guide near-term positioning in equities.
FAQs
Q: What is Vinay Rajani’s Nifty 50 view in the near term?
- Nifty is seen consolidating between 23,800 and 24,200, with 23,800 as key support and 24,200 as resistance. A close above 24,200 could target around 24,450, while a break below 23,800 may lead toward 23,500 to 23,300.
Q: Which sectors does Rajani expect to outperform?
- Rajani highlights banks, NBFCs and healthcare as relatively stronger. He suggests using strength in these sectors to add selectively, while broader markets show some loss of momentum.
Q: What are the key levels for L&T Finance, Gland Pharma and Welspun Enterprises?
- L&T Finance: buy near ₹300 to ₹302 with stop around ₹295 to ₹295.8 and targets up to ₹332. Gland Pharma: buy around ₹2,360 with stop at ₹2,310 and target of ₹2,470. Welspun Enterprises: buy near ₹573 with stop at ₹514 and target of ₹640.
Frequently Asked Questions
What is Vinay Rajani’s Nifty 50 view in the near term?
He sees Nifty consolidating between 23,800 and 24,200, with 23,800 as key support and 24,200 as resistance. A close above 24,200 could target around 24,450, while a break below 23,800 may lead toward 23,500 to 23,300.
Which sectors are expected to outperform according to Rajani?
Banks, NBFCs and healthcare are seen as relatively stronger. Rajani suggests using strength in these sectors to add selectively, while midcaps and smallcaps show softer breadth.
What trading levels are suggested for L&T Finance, Gland Pharma and Welspun Enterprises?
L&T Finance: buy near ₹300–302 with stop around ₹295–295.8 and targets up to ₹332. Gland Pharma: buy around ₹2,360 with stop at ₹2,310 and target of ₹2,470. Welspun Enterprises: buy near ₹573 with stop at ₹514 and target of ₹640.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.
